What We're Reading: Page 221
Industry reads hand-picked by our editors
May 02, 2019
-
The Economist
Antibiotics biotech firms are struggling
-
BioCentury
China makes headway on trade secret reform
-
Boston Business Journal
Charles River Labs says its biotech, pharma clients' data was hacked
-
Bloomberg
Crispr babies vs. 'bubble boy': only one was about the patient
May 01, 2019
Apr 30, 2019
-
The Washington Post
Why Vermont's single-payer effort failed and what Democrats can learn from it
-
In the Pipeline
The Going Rates, 2019 Edition
-
CNN
Our antibiotics are no match for superbugs, and it's a 'global crisis,' UN report says
-
Reuters
Novartis's Sandoz strikes deal for biosimilar of Herceptin
Apr 29, 2019
-
The Wall Street Journal
Cancer-drug giant Roche loses edge as rivals grow
-
Kaiser Health News
Is insulin's high cost keeping diabetes patients from taking their medicine?
-
Bloomberg
Snoop Dogg-backed medical weed firm seeks big pharma funding
-
Reuters
The obscure advisory committees at the heart of the U.S. drug pricing debate
Previous
